EGINX | VEURX | EGINX / VEURX | |
Total Expense Ratio | 1.33 | 0.24 | 554% |
Annual Report Gross Expense Ratio | 1.33 | 0.24 | 554% |
Fund Existence | 22 years | 35 years | - |
Gain YTD | 13.323 | 23.877 | 56% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 503M | 32.9B | 2% |
Annual Yield % from dividends | 3.40 | 2.88 | 118% |
Returns for 1 year | -5.25 | 11.83 | -44% |
Returns for 3 years | 26.18 | 51.73 | 51% |
Returns for 5 years | 4.35 | 44.81 | 10% |
Returns for 10 years | 16.09 | 57.65 | 28% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
QCLN | 38.57 | 0.37 | +0.97% |
First Trust NASDAQ® Cln Edge® GrnEngyETF | |||
EBI | 53.93 | 0.05 | +0.10% |
The RBB Fund Trust Longview Advantage ETF | |||
HIDV | 78.16 | 0.04 | +0.05% |
AB US High Dividend ETF | |||
IBDS | 24.31 | -0.01 | -0.04% |
iShares iBonds Dec 2027 Term Corp ETF | |||
SSG | 10.50 | -0.02 | -0.19% |
ProShares UltraShort Semiconductors |